Block on Trump's Asylum Ban Upheld by Supreme Court
Latisse wants you to "Look who's growing longer, fuller, darker lashes." Unfortunately for Latisse and it maker Allergan, Inc., the FDA wants you to look at who may be growing unwanted non-eyelash hair, getting brown pigmentation (possibly permanent) in their irises, getting brown pigmentation on their eyelids, and possibly having allergic reactions.
Here is the warning letter sent by the FDA to Latisse maker Allergan, who brought us Botox, amongst other hit cosmetic drugs.
The FDA is concerned about the "FAQs" and "About Safety" pages on the Latisse website. It appears, that in addition to watching Brooke Shields' remarkable eyelash journey made possible by Latisse, consumers might encounter some less than forthcoming claims about risks associated with the cosmetic drug.
This is not about failure to include something in the fine print of an ad or laundry list at the end of a TV commercial, but instead about the website where consumers go to find out basic information about what risks Latisse might pose.
The FDA's problems with the Latisse site include:
The FDA has demanded that Allergan respond by September 24 and get rid of the misleading claims.
Sign into your Legal Forms and Services account to manage your estate planning documents.Sign In
Create an account allows to take advantage of these benefits: